$ATEX

Guttman-McCabe Christopher sold $2.2M of ATEX

Guttman-McCabe Christopher (Chief Reg & Comm Officer) sold 23,439 shares of Anterix Inc. (ATEX) at an average of $92.36 ($90.61–$93.59, $2.16M total) across 4 trades on 2026-08-25.

Original reporting
SEC EDGAR · Guttman-McCabe Christopher
Published Aug 27, 2026, 8:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATEX
Bearish
medium confidence
Mentioned
$ATEX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATEXBearishLow
01

Why it matters

The filing provides the first public record of the insider's sale, offering new data for traders.

02

Market read

A $2.1 M insider sale by a senior officer may influence short‑term sentiment for ATEX.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed could be driving the sale.

Relevance 6/10Novelty 4/10Timing: filed today (2026‑08‑27)

Background

SEC Form 4 filing discloses insider transactions; required for transparency.

Company-level read

Ticker impact

$ATEXBearishMedium confidence
Context

Chief Reg & Comm Officer sold 23,439 shares for $2.16M in a Form 4 filing.

Expected impact

modest short‑term downside as the market digests the $2M sell‑off.

Evidence & confidence

Insider sales of this size are uncommon for ATEX and can trigger sell pressure, especially given the officer's senior role.

Market effects

Minimal impact on the broader telecom equipment sector; only a single insider transaction.

No discernible regional effect; ATEX trades primarily on U.S. exchanges.

Limited global relevance; the filing is a routine disclosure.

Counterpoint

The sale could be unrelated to confidence and merely a personal liquidity need; price may remain stable.

Key entities

  • Anterix Inc.

    U.S. listed telecom equipment provider (ticker ATEX).

  • Guttman‑McCabe Christopher

    Chief Regulatory & Communications Officer at Anterix.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026. Financial and Operational Highlights –

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2